Orphenadrine Citrate 43386-0480-28
- Manufacturer
- Lupin Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 19, 1998
- Listing Expires
- December 31, 2026
- Application
- ANDA040284
Need to source Orphenadrine Citrate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Orphenadrine Citrate | 100 mg/1 |
Drug Class
Centrally-mediated Muscle Relaxation [PE]Muscle Relaxant [EPC]
Selected Package
43386-0480-28Selected1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (43386-480-28)
Other packages for this product(2)
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (43386-480-24)
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43386-480-26)